01 Oct 2025 | 3 Mins Read
Pfizer stocks boost 8% after Medicaid agreement with Trump
Flipitmoney
Pfizer shares jumped 8% as the US drugmaker agreed to lower Medicaid prescription drug costs, invest $70 billion in research and development, and domestic manufacturing. The deal includes a three-year tariff exemption, participation in TrumpRx, and matching US prices to lowest foreign prices, with discounted treatments averaging 50% on TrumpRx.